Constellation Pharmaceuticals Lands $22,000,000 Series B Funding Round

  • Feed Type
  • Date
    6/2/2010
  • Company Name
    Constellation Pharmaceuticals
  • Mailing Address
    148 Sidney Street Cambridge, MA 02139
  • Company Description
    Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
  • Website
    http://www.constellationpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to advance the development of Constellation’s pipeline of compounds towards the clinic. These funds will also enable Constellation to continue applying its innovative epigenetics product engine to probe multiple classes of novel drug targets involved in chromatin regulation and disease.
  • M&A Terms
  • Venture Investor
    SR One
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Venrock
  • Venture Investor
    The Column Group
  • Venture Investor
    Altitude Life Science Ventures

By posting a comment, you agree to our terms and conditions.